Since 1974 a creative and efficient global niche player in the field of medical publishing

Havener's Ocular Pharmacology

7th Edition

edited by: T.F. Mauger & L.C. Laxson & M. Slabaugh

Price: € 90.00 / US $ 100.00

Add to cart

Publication details: Book. 2022. xviii and 366 pages. Publication date: 2022-04-22. Hardbound. A4

ISBN: 978-90-6299-278-2 (ISBN 10: 90-6299-278-1; Kugler Publications)



It is humbling to know the book we three, and our many contributors, labored to complete was accomplished by a single author not once, but five times. Two of us trained as residents under Dr. Havener and can attest that he was a remarkable human being. He was able to both quote philosophy and the latest paper at Grand Rounds while growing the largest pumpkins in the county, which he loved to give to the children of his trainees and faculty at annual picnics on his farm. He was extraordinarily devoted to his patients and was for many years one of the few ophthalmologists in the Midwest performing scleral buckling surgery for retinal detachments.

The rapidity of change in medicine and medical therapy has only accelerated since 1983. Many new classes of drugs are available since the last edition, including the prostaglandin analogs, vascular endothelial growth factor inhibitors, and Rho-kinase inhibitors. At the same time, many older drugs are now rarely or never used.

The goal of this text is to help frame the old and the new in ocular pharmacology for physicians, optometrists, and students of pharmacology and visual science. Our hope is that this book will serve as a guide to current medications and also provide a framework to aid the reader in properly positioning new therapeutic options as they become available.

We want to acknowledge the tremendous work of all of the contributors. Andrea Inman at The Ohio State University coordinated the authors and students. Will Bloom, Valerie Mauger, and Nathaniel Dusseau labored for many hours as student assistants in the referencing and editing of many of the chapters of this edition; their assistance was invaluable. We also wish to acknowledge the advice and work of our publisher, Simon Bakker.

Most importantly, we want to thank our editor Silvia Sanchez Di Martino, whose tireless efforts through challenging times are responsible for this text being completed. Her attention to detail in the diverse areas and many references was remarkable. Any remaining deficiencies are totally accountable to the authors.

Finally, the culture of an academic institution is critical to allow a work such as this to be completed. We are blessed to have outstanding and supportive Deans at our Medical Schools at The Ohio State University, West Virginia University, and at the various other academic medical centers represented by our many contributors.

Thomas F. Mauger, MD L.
Carol Laxson, MD, PhD
Mark Slabaugh, MD

Table of Contents

Table of Contents



Basic Concepts

1. Ocular Pharmacokinetics
David Hinkle, Thomas F. Mauger

2. Ocular Pharmacology in Pregnancy
Catherine O. Jordan

3. Pediatric Ocular Pharmacology
Sarah Hilkert Rodriguez

Autonomic and Glaucoma Drugs

4. Adrenergic Agonists (Sympathomimetics)
Gloria Fleming, William Bloom, Tony Realini

5. Alpha-Adrenergic Antagonists
Mark Slabaugh

6. Beta-Adrenergic Antagonists
Brian McMillan, Shelly G. Jain

7. Cholinergic Agents
Daniel B. Moore

8. Anticholinergic Agents
Daniel B. Moore

9. Carbonic Anhydrase Inhibitors
Mark Slabaugh

10. Ocular Anesthetics
Rebecca A. Kuennen

11. Prostaglandin Analogues
Derek Horkey

12. Rho-Associated Kinase (ROCK) Inhibitors
Mark Slabaugh, Thomas F. Mauger

13. Osmotic Agents
L. Carol Laxson


14. Antibacterials
Ankit Shah, Thomas F. Mauger

15. Antivirals Tyler
D. Oostra

16. Antifungals
L. Carol Laxson, Thomas F. Mauger

17. Antiparasitics
Irina Livshitz

18. Germicides
Thomas F. Mauger

Anti-Inflammatory Agents

19. Corticosteroids
Julie Lew, Caleb Liles

20. Nonsteroidal Anti-Inflammatory Drugs
William R. Bloom, Matthew P. Ohr

21. Immunomodulatory Agents
Adnan Mallick, David Hinkle

22. Biological Anti-Inflammatory Agents
Julie Lew, Oben Ojong

Retinal Pharmacology

23. Vascular Endothelial Growth Factor Inhibitors
Alan D. Letson

24. Vitamins and Supplements
Ghassan Ghorayeb, Thomas F. Mauger

Surgical Pharmacology

25. Vitreous Substitutes
Michael Wells, Cecelia Favede, James Kasenchak

26. Viscoelastic Substances (Ophthalmic Viscosurgical Devices)
Amit Tandon

27. Tissue Adhesives
Raymond I. Cho, Jonathan K. Ramsey

28. Neurotoxins for Therapeutic Chemodenervation
Jamie L Schaefer, Bradley A. Thuro, John Nguyen

29. Soft Tissue Fillers
Raymond I. Cho, Julie A. Woodward


Kugler Publications
Postal address:
P.O. Box 20538
1001 NM Amsterdam
The Netherlands
Tel: +31 20 68 45 700